Related Experiment Video
Updated: May 12, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Machine Learning Algorithm-Based Discovery of Potential Regulators of Immune-Related Dilated Cardiomyopathy
Yi-Ting Yang1, Bao Zhen2, Xue Cao1
1Department of Cardiovascular Medicine, Songbei Branch of the Fourth Affiliated Hospital of Harbin Medical University.
Insights
Machine learning identified five immune-related genes as potential biomarkers for early dilated cardiomyopathy (DCM) detection. This discovery offers a new strategy for diagnosing and treating this severe heart condition.
Area of Science:
- Genomics
- Immunology
- Cardiology
Background:
- Dilated cardiomyopathy (DCM) is a severe myocardial disease with no effective early detection methods.
- Current diagnostic approaches lack the precision needed for timely intervention and targeted therapy.
Purpose of the Study:
- To leverage machine learning algorithms for identifying novel biomarkers for early DCM detection.
- To guide clinical drug development and precision medicine strategies for DCM management.
Main Methods:
- Utilized Gene Expression Omnibus datasets for DCM patients and healthy controls.
- Identified differentially expressed genes (DEGs) and filtered for immune-related genes (Immune-DEGs).
- Applied LASSO and SVM algorithms to screen for key modulators, followed by ROC curve analysis and immune infiltration analysis.
Main Results:
- Identified 184 differential immune genes, highlighting roles for inflammation, immune disorders, and viral infections in DCM pathogenesis.
- Screened five signature genes: KLRC4, CCL4, IGHV3-33, ITGAL, and inducible T-cell kinase, using LASSO and SVM.
- Validated the diagnostic efficacy of these five genes on independent external data.
Conclusions:
- A gene set of five immune-related genes was constructed as potential regulators for DCM.
- This gene set offers a promising new strategy for the diagnosis and treatment of dilated cardiomyopathy.
Purpose:
Dilated cardiomyopathy (DCM) is considered a severe non-ischemic myocardial disease, and there is currently no effective method for the early detection of DCM. Therefore, we aimed to use machine learning algorithms to discover more accurate factors to guide clinical drug development and precision medicine diagnosis.
Methods:
Two datasets containing patients with DCM and healthy controls were downloaded from the Gene Expression Omnibus database. After data preprocessing, differentially expressed genes (DEGs) between the DCM patients and normal samples were identified using the limma package. In addition, to screen for DEGs closely associated with immune inflammation, we collected immune-related genes and defined overlapping genes as differential immune genes (Immune-DEGs). Protein-protein interaction (PPI) network construction and functional enrichment analysis were then functionally validated for the differential immune genes. Subsequently, we further screened the immune-DEGs using the least absolute shrinkage and selection operator (LASSO) technique and support vector machine algorithm (SVM), resulting in the screening of five potential modulators closely associated with DCM. Finally, the diagnostic efficacy of the modifiers was assessed using subject operating characteristic curves based on independent external data, and the intrinsic pathological mechanisms of different differential immune genes were explored by immune infiltration analysis.
Results:
A consensus of 184 differential immune genes were identified, and the functional enrichment results of their PPI network modules suggested that inflammation, immune disorders, and viral infections play an essential role in the pathogenesis of DCM. Five signature genes were then further screened using LASSO and SVM algorithms: KLRC4, CCL4, IGHV3-33, ITGAL, and inducible T-cell kinase.
Conclusions:
This study constructed a gene set of potential DCM regulators with five immune-related genes, which could provide a new strategy for the diagnosis and treatment of DCM.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy